Notify me when Michael P. Dube files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | VP, Chief Accounting Officer | $868,392 | -$84,952 | -8.9% | 01 Mar 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|